HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

HealthEquity reports robust Q3 growth amidst challenges and opportunities

HealthEquity's Q3 performance reflects strong growth and market positioning, despite challenges in gross profit margins.
The company's focus on legislative support, technology utilization, and diversified revenue streams positions it well for future expansion.
Opportunities in expanding the TAM, enhancing service delivery, and leveraging commuter offerings indicate a promising outlook for HealthEquity.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

Why Is HealthEquity (HQY) Down 10% Since Last Earnings Report?

HealthEquity (HQY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Here's Why HealthEquity (HQY) is Poised for a Turnaround After Losing 7.7% in 4 Weeks

HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust segmental revenues, in the first quarter of fiscal 2023.

HealthEquity (HQY) Q1 Earnings Lag Estimates, FY23 View Up

HealthEquity, Inc. (NASDAQ:HQY ) Q1 2023 Earnings Conference Call June 7, 2022 4:30 PM ET Company Participants Richard Putnam - Investor Relations Jon Kessler - President and Chief Executive Officer Ted Bloomberg - Executive Vice President and Chief Operating Officer Tyson Murdock - Executive Vice President and Chief Financial Officer Steve Neeleman - Vice-Chair and Founder Conference Call Participants Anne Samuel - JPMorgan Greg Peters - Raymond James George Hill - Deutsche Bank Stephanie Davis - SVB Securities Glen Santangelo - Jefferies Stan Bernstein from - Wells Fargo Sandy Draper - Guggenheim Mark Marcon - Baird Allen Lutz - Bank of America David Larsen - BTIG Thomas Kelliher - RBC Capital Markets Operator Good day and thank you for standing by, and welcome to HealthEquity First Quarter 2023 Earnings Call. I would now like to hand the conference over to your host today, Richard Putnam.

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q1 2023 Results - Earnings Call Transcript

HealthEquity (HQY) delivered earnings and revenue surprises of -3.57% and 1.46%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) Q1 Earnings Miss Estimates

HealthEquity Reports First Quarter Ended April 30, 2022 Financial Results

Coupa Software

InspireMD

OceanPal

Science Applications International

Some of the stocks that may grab investor focus today are: Wall Street expects Science Applications International Corporation (NYSE: SAIC) to report quarterly earnings at $1.77 per share on revenue of $1.93 billion before the opening bell. SAIC shares rose 2.2% to $90.00 in after-hours trading.

5 Stocks To Watch For June 6, 2022

Company honored with two awards for employee wellness initiatives Company honored with two awards for employee wellness initiatives

HealthEquity Named as One of The Healthiest Workplaces

HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.

HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q4 2022 Results - Earnings Call Transcript

HealthEquity (HQY) delivered earnings and revenue surprises of -4.76% and 2.02%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) Q4 Earnings Miss Estimates

HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2022 Financial Results

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: HealthEquity (HQY) Q4 Earnings Expected to Decline

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has removed from under review with negative implications and affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of MII Life Insurance, Incorporated (MII Life) (Eagan, MN). The outlook assigned to these Credit Ratings (ratings) is stable. The ratings reflect MII Life's balance sheet strength, which AM Best assesses as adequate, as well as its adequate operating performance, limited business profile

AM Best Removes From Under Review With Negative Implications and Affirms Credit Ratings of MII Life Insurance, Incorporated

Receives recognition after employees give HealthEquity high marks in national independent survey Receives recognition after employees give HealthEquity high marks in national independent survey

HealthEquity Named One of the Nation's Top Workplaces

Presentation at Conference Presentation at Conference

HealthEquity Sets Date to Announce FY22 Results

The HSA specialist suffered during the pandemic, but the long-term trends for it still look favorable.

Are Brighter Times Ahead for HealthEquity Stock in 2022?

DRAPER, Utah, Feb. 01, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest independent health savings account (“HSA") custodian, announced that it plans to release its fiscal year-end sales results following the close of regular stock market trading hours on Tuesday, February 22, 2022. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, February 22, 2022, at 4:30 pm ET during which management will review January 31, 2022, year-end sales results.

HealthEquity Announces Reporting Date of FY22 Sales Results Presentation at Conferences

The company unveiled some highly encouraging growth statistics.

Why HealthEquity Stock Was Winning Big This Week

HealthEquity (HQY) Up 10.3% Since Last Earnings Report: Can It Continue?

AeroVironment

Not every company participated in the rally.

Why These 2 Stocks Got Crushed in a Booming Market

The stock price of Healthequity Inc (NASDAQ: HQY) fell by over 20% during intraday trading. This is why it happened.

Healthequity Stock (HQY): Why The Price Substantially Dropped

On Tuesday, Healthequity Inc. (NASDAQ:HQY) shares declined by 24% after announcing its most recent quarterly results. The company reported its FQ3 revenue and earnings Monday after markets closed, missing the consensus for analyst expectations.

Is it safe to buy Healthequity stock after plunging 24% after earnings?

HealthEquity Inc. (NASDAQ: HQY), a top HSA (health savings account) non-bank custodian, dropped by 25% and announced its third-quarter financial results for 2021.  How does top management feel?

HealthEquity went down by 25% and announced its third-quarter financials for 2021

HealthEquity (HQY) witnesses solid growth in HSAs besides recording robust Interchange revenues in the third quarter of fiscal 2022.

News for HealthEquity Stock (HQY)